🇺🇸 FDA
Patent

US 6616925

Combined preparation for the treatment of neoplasic diseases or of infectious diseases

expired A61KA61K2239/31A61K2239/38

Quick answer

US patent 6616925 (Combined preparation for the treatment of neoplasic diseases or of infectious diseases) held by I.D.M. Immuno-Designed Molecules expires Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
I.D.M. Immuno-Designed Molecules
Grant date
Tue Sep 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2239/31, A61K2239/38, A61K2239/48, A61K2239/50